Target intelligence / Profile preview

Host cell sialic acid glycans (Sia-glycans)

Target
Sia-glycans
Molecular classification
Carbohydrate, Glycan, Post-translational modification
01

Overview

Host cell sialic acid glycans are terminal sugar residues found on the surface of almost all vertebrate cells, typically attached to glycoproteins and glycolipids. They play a critical role in biological processes such as cell-cell adhesion, signaling, and the regulation of the immune system through interactions with Siglecs (sialic acid-binding immunoglobulin-type lectins) (Varki, 2008, Nature). In the context of infectious diseases, many pathogens, including influenza viruses and certain coronaviruses, utilize host cell sialic acids as primary receptors for attachment and entry (Matrosovich et al., 2015, Journal of Molecular Biology). In oncology, hypersialylation of the cell surface is a hallmark of many cancers, contributing to immune evasion by creating a "sialic acid shield" that inhibits natural killer cell and T-cell activity via Siglec binding (Gray et al., 2020, Nature Chemical Biology). Therapeutic strategies targeting these glycans include the use of sialidases to strip the sugars from the cell surface or small molecule inhibitors that prevent viral enzymes from interacting with them (Malaker et al., 2018, PNAS).

Other names
Sialylated glycansSialosidesN-acetylneuraminic acid (Neu5Ac) glycansNeuraminic acid derivativesTerminal sialic acids
02

Mechanism of action

Inhibition of viral neuraminidase to prevent cleavage of sialic acid and viral release; enzymatic removal of terminal sialic acids from host cell surfaces to prevent viral entry or enhance anti-tumor immune responses; blocking of sialic acid-binding sites on pathogens or host receptors.

03

Biological functions

Cell-cell recognitionCell signalingImmune regulationPathogen attachmentProtein stabilityCell adhesion
04

Disease associations

InfectionCancerInflammationAutoimmune disease
05

Safety considerations

Disruption of normal immune signaling (Siglec-mediated)Potential for systemic toxicity if host glycans are broadly degradedAlteration of protein half-life and clearancePotential for increased susceptibility to secondary infections
06

Interacting drugs

Oseltamivir

6 more in the full profile.

07

Biomarkers

Sialyl-Lewis X (sLeX)Total serum sialic acid (TSSA)Alpha-2,3-linked sialic acid expressionAlpha-2,6-linked sialic acid expression

Beyond the preview

Go deeper on Host cell sialic acid glycans (Sia-glycans).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host cell sialic acid glycans (Sia-glycans).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call